Charles Winter
Chief Tech/Sci/R&D Officer bei JANUX THERAPEUTICS, INC.
Vermögen: - $ am 31.03.2024
Profil
Charles Winter is currently the Chief Technical Officer at Janux Therapeutics, Inc. Prior to this, he worked as the Director of Biologics Development at Gilead Sciences, Inc. from 2011 to 2015, and as the Vice President of Manufacturing & Technology at Eden Biologics, Inc. from 2015 to 2016.
Winter received his undergraduate degree from the University of Wisconsin.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
JANUX THERAPEUTICS, INC.
-.--% | 02.01.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Charles Winter
Unternehmen | Position | Beginn |
---|---|---|
JANUX THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01.01.2021 |
Ehemalige bekannte Positionen von Charles Winter
Unternehmen | Position | Ende |
---|---|---|
JHL BIOTECH, INC. | Chief Tech/Sci/R&D Officer | 01.08.2016 |
GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01.06.2015 |
Ausbildung von Charles Winter
University of Wisconsin | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
JANUX THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Eden Biologics, Inc.
Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Eden Biologics, Inc. is engaged in the manufacture and sale of bio-pharmaceuticals products. It offers cell line cloning, antibody cloning, monoclonal antibody, cell line development, master and working cell banks, cell culture process development, purification process development, formulation development, and analytical assays. The company was founded on June 14, 2012 and is headquartered in Zhupei, Taiwan. | Health Technology |